Myeloid Leukemia — Trials

Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

3,528 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 862
Recruiting: 498
Ph III recruiting: 47
Growth YoY: +4.1%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (617)

clinicaltrialsPublishedShowing 101–105 of 105 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00580281	Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors	completed	N/A	33	Memorial Sloan Kettering Cancer CenterOTHER	1	Oct 24, 2013	clinicaltrials
NCT00478985	Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia(STIM)	completed	N/A	100	University Hospital, BordeauxOTHER	1	Jul 2, 2013